Research and Markets: Global Neurodiagnostic and Monitoring Devices Market Assessment & Forecast: 2015-2019

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/vg6p5v/global) has announced the addition of the "Global Neurodiagnostic and Monitoring Devices Market Assessment & Forecast: 2015-2019" report to their offering.

In terms of geography, North America and Europe are expected to continue leading due to several folds greater level of awareness and research activity in the neurological domain. Asia-Pacific, Middle-East and Latin America will present strong growth riding on the large number of opportunities the emerging economies offer to manufacturers for revenue growth.

Emerging countries have invested greatly in healthcare infrastructure and are now shifting focus to research in conventionally low priority areas due to increased awareness of certain diseases such as epilepsy, autism and neurodegenerative diseases to combat their rising incidence across the world. It is estimated that over 20 million people suffer from epilepsy in the Asia-Pacific region. The neurodiagnostic monitoring market has not caught up to its true commercial potential as only clinics and research institutes are relying on major portion of technology. Thus a large number of manufacturers are currently catering only to the neuro-labs and clinics.

Diagnostics of irregular episodes of epileptic attacks is a core part of neuromonitoring and the same is not accessible to several thousand patients in the region. According to a report by the WHO on epilepsy in Latin America and Caribbean, ratios of 1.18 neurologists and 0.78 neurosurgeons per 100,000 populations were reported in Latin America and 12 LAC countries reported having 2 physicians with special training in epilepsy (epileptologists).

In Asia rising incidence of neurological disorders such as Alzheimer's, Parkinson's, epilepsy among other brain disorders and stroke is expected to fuel growth of monitoring devices in the neurological segment. 2014 estimates suggest that there are over 13 million people suffering from epilepsy and over 75 million people are affected by severe brain disorders. Increasing incidence of head trauma is also believed to influence the growth and adoption of modern life-saving devices.

Key Topics Covered:

1. Preface

2. Introduction

3. Market Dynamics

4. Neurodiagnostic and Monitoring Devices - Global Market Size Assessment by Products, Forecast: 2015 - 2019

5. Neurodiagnostic and Monitoring Devices - Global Market Size Assessment, by End-Users, Forecast: 2015 - 2019

6. Neurodiagnostic and Monitoring Devices - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019

7. Key Players Analysis: Global Computed Tomography Systems Market, 2014 (%)

8. Epilogue

Companies Mentioned

- CTF MEG Technologies

- Cadwell Laboratories & Advanced Brain Monitoring

- Compumedics

- Covidien

- Elekta

- Nihon Kohden

- Tristan Tech

- Yokogawa Corporation

For more information visit http://www.researchandmarkets.com/research/vg6p5v/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices